ACADIA Pharmaceuticals (ACAD) News Today $21.31 -0.23 (-1.07%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$21.32 +0.02 (+0.07%) As of 10/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACADOctober 8 at 4:36 PM | prnewswire.comQ3 EPS Estimate for ACADIA Pharmaceuticals Cut by AnalystOctober 8 at 7:30 AM | marketbeat.comAcadia Healthcare names Todd Young CFOOctober 7 at 10:45 PM | msn.comBrokerages Set ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Price Target at $29.12October 7 at 2:59 AM | americanbankingnews.comACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain BullishOctober 6 at 10:55 AM | seekingalpha.comWealth Enhancement Advisory Services LLC Makes New $511,000 Investment in ACADIA Pharmaceuticals Inc. $ACADOctober 6 at 3:07 AM | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Moderate Buy" by AnalystsOctober 4, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACADOctober 3, 2025 | prnewswire.comAcadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®October 2, 2025 | finance.yahoo.comAcadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson's Disease and Movement Disorders®October 2, 2025 | businesswire.comJPMorgan Chase & Co. Has Lowered Expectations for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceOctober 1, 2025 | americanbankingnews.comJP Morgan Maintains ACADIA Pharmaceuticals (ACAD) Overweight RecommendationSeptember 29, 2025 | msn.comBeyond The Numbers: 11 Analysts Discuss ACADIA Pharmaceuticals StockSeptember 29, 2025 | benzinga.comACADIA Pharmaceuticals (NASDAQ:ACAD) Given New $33.00 Price Target at JPMorgan Chase & Co.September 29, 2025 | marketbeat.comAcadia to stop development of rare disease therapy after trial failureSeptember 25, 2025 | msn.comAcadia Pharma Tumbles On Failed Genetic Disease Drug; Soleno SurgesSeptember 25, 2025 | msn.comAcadia Pharmaceuticals Shares Drop After Phase 3 PWS Trial Misses Primary GoalSeptember 25, 2025 | msn.comAcadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To HoldSeptember 25, 2025 | seekingalpha.comACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap Down Following Analyst DowngradeSeptember 24, 2025 | marketbeat.comNeedham & Company LLC Has Lowered Expectations for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceSeptember 24, 2025 | marketbeat.comTraders Buy Large Volume of ACADIA Pharmaceuticals Call Options (NASDAQ:ACAD)September 24, 2025 | marketbeat.comAcadia Pharma Tumbles On Failed Appetite Suppressant; Soleno SurgesSeptember 24, 2025 | investors.comAcadia stock falls after Phase 3 PWS trial fails to meet primary endpointSeptember 24, 2025 | za.investing.comAcadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage StudySeptember 24, 2025 | msn.comAcadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary EndpointSeptember 24, 2025 | finance.yahoo.comAcadia Pharmaceuticals Shares Halted as ACP-101 Trial Misses Primary EndpointSeptember 24, 2025 | marketwatch.comAcadia Pharmaceuticals' rare disease therapy fails late-stage trialSeptember 24, 2025 | reuters.comACADIA Pharmaceuticals Inc. $ACAD Shares Purchased by Voya Investment Management LLCSeptember 24, 2025 | marketbeat.comBioFuture™ 2025 Explores the Next Era of Innovation, Policy, and Investment in BiopharmaSeptember 23, 2025 | finance.yahoo.comAssenagon Asset Management S.A. Cuts Stock Holdings in ACADIA Pharmaceuticals Inc. $ACADSeptember 22, 2025 | marketbeat.comKingstone Capital Partners Texas LLC Buys Shares of 15,600 ACADIA Pharmaceuticals Inc. $ACADSeptember 22, 2025 | marketbeat.com12,664 Shares in ACADIA Pharmaceuticals Inc. $ACAD Acquired by Pallas Capital Advisors LLCSeptember 22, 2025 | marketbeat.comCitizens JMP Reaffirms Their Buy Rating on ACADIA Pharmaceuticals (ACAD)September 20, 2025 | theglobeandmail.comStrs Ohio Takes $796,000 Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 20, 2025 | marketbeat.comACADIA Pharmaceuticals EVP Trades $82K In Company StockSeptember 17, 2025 | benzinga.comACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Sells $82,727.70 in StockSeptember 17, 2025 | marketbeat.comMark Schneyer Sells 3,498 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) StockSeptember 17, 2025 | insidertrades.comACADIA Pharmaceuticals Inc. $ACAD Shares Acquired by Wesbanco Bank Inc.September 16, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. $ACAD Shares Acquired by Rhumbline AdvisersSeptember 15, 2025 | marketbeat.comWoodline Partners LP Acquires 268,445 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 15, 2025 | marketbeat.comACADIA Pharmaceuticals (ACAD) Reports Positive Interim Results From Rett Syndrome StudySeptember 13, 2025 | finance.yahoo.comTD Cowen Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) StockSeptember 13, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and ACADIA Pharmaceuticals (ACAD)September 12, 2025 | theglobeandmail.comReal World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child NeurologySeptember 12, 2025 | businesswire.comAcadia Pharmaceuticals price target raised to $39 from $35 at TD CowenSeptember 11, 2025 | msn.comACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi SyndromeSeptember 11, 2025 | finance.yahoo.comUBS Group Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceSeptember 11, 2025 | marketbeat.comGreat Lakes Advisors LLC Acquires 72,667 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 11, 2025 | marketbeat.comScientech Research LLC Has $628,000 Stock Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 11, 2025 | marketbeat.comFred Alger Management LLC Increases Stock Holdings in ACADIA Pharmaceuticals Inc. $ACADSeptember 10, 2025 | marketbeat.com Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACAD Media Mentions By Week ACAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼0.240.63▲Average Medical News Sentiment ACAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼1112▲ACAD Articles Average Week Get the Latest News and Ratings for ACAD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News Viatris News Dr. Reddy's Laboratories News Roivant Sciences News Moderna News Qiagen News BridgeBio Pharma News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
